Nonablative neonatal marrow transplantation attenuates functional and physical defects of β-glucuronidase deficiency

Blood

Volumn 97, Issue 5, 2001, Pages 1498-1504

  Soper, Brian W ^a   Lessard, Mark D ^b   Vogler, Carole A ^b   Levy, Beth ^b   Beamer, Wesley G ^b   Sly, William S ^b   Barker, Jane E ^b  

^a JACKSON LABORATORY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; GLYCOSAMINOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CORTICAL BONE; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HISTOCHEMISTRY; LIFESPAN; MALE; MOUSE; MUCOPOLYSACCHARIDOSIS TYPE 7; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035283136     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.5.1498     Document Type: Article

References (48)

1. Transplantation in relation to the treatment of inherited disease
2. Bone marrow transplants in genetic diseases
3. Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency
4. Bone marrow transplantation, II: Use for aplastic anemia, hereditary diseases, and hemoglobinopathies
5. The mucopolysaccharidoses
6. Bone-marrow transplantation for metachromatic leucodystrophy
7. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation
8. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates
9. Long-term outcome of Hurler syndrome following bone marrow transplantation
10. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome
11. Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome
12. The relationship between the spleen colony-forming cell and the haemopoietic stem cell
13. Fate of chromosome-marked mouse bone marrow cells tranfused into normal syngeneic recipients
14. Proliferation of donor hematopoietic cells in irradiated and unirradiated host mice
15. Proliferation of donor spleen and bone-marrow cells in the spleens and bone marrows of unirradiated and irradiated adult mice
16. Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice
17. Repetitive bone marrow transplantation in nonmyeloablated recipients
18. Stem cell transplantation in the normal nonmyeloablated host: Relationship between cell dose, schedule, and engraftment
19. Murine mucopolysaccharidosis type VII: Characterization of a mouse with beta-glucuronidase deficiency
20. A murine model of mucopolysaccharidosis VII: Gross and microscopic findings in beta-glucuronidase-deficient mice
21. Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis
22. Behavioural abnormalities in a murine model of a human lysosomal storage disease
23. Enzyme replacement therapy improves reproductive performance in mucopolysaccharidosis type VII mice but does not prevent postnatal losses
24. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation
25. Enzyme replacement therapy for murine mucopolysaccharidosis type VII
26. Enzyme replacement with recombinant β-glucuronidase in the newborn mucopolysaccharidosis type VII mouse
27. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: Impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival
28. Enzyme replacement in murine mucopolysaccharidosis type VII: Neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy
29. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function
30. β-Glucuronidase binding to human fibroblast receptors
31. Murine mucopolysaccharidosis type VII: A model system for somatic gene therapy of the central nervous system
32. Percutaneous intravenous injection in neonatal mice
33. Large scale purification of phosphorylated recombinant human β-glucuronidase from over expressing mouse L cells
34. Genetic variability in adult bone density among inbred strains of mice
35. Bone stem cells
36. The microglial cell: A historical review
37. Kinetics of central nervous system microglial and macrophage engraftment: Analysis using a transgenic bone marrow transplantation model
38. Mature monocytic cells enter tissues and engraft
39. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation
40. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates
41. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy
42. Hurler syndrome, II: Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children
43. Developments of a water-maze procedure for studying spatial learning in the rat
44. Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII
45. Short- and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice: Models for human umbilical cord blood
46. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen
47. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model
48. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand